amongst which replacement or relative donors were 30868 (92%), voluntary donors 2685 (8%) and male donors 27722 (82.62%), female donors 5831 (17.38%). Among the donors 15133 (45.10%), were of age group between 18-25 years, 17809 (53.08%) were of age group between 26-45 years, and 611 (1.82%) were of age group between 46-60 years. The purpose of this study was to determine the sero-prevalence
Introduction
According to World Health Organization (WHO) study and data around the world regarding blood safety, about 80% of world's population does not have access to safe blood (Global Data Base). Despite limited resources, rapid spread of HIV/AIDS and other TTIs, transfusion of safe blood and blood component has to be ensured to reduce morbidity and mortality. 1 Screening of blood and blood components varies from country to country depending on the availability of resources and adequate trained manpower. The objective of this study was to determine the sero-prevalence of HIV, HBV, HCV, Syphilis and Malaria in blood donors attending in Blood Transfusion Department of Chittagong Medical College Hospital, Chittagong, Bangladesh. Since the inception of Safe Blood Transfusion program, screening of the donated blood for TTIs has emerged a new era in Bangladesh. As per Safe Blood Transfusion Law-2002, screening of HBV, HCV, HIV, Syphilis and Malaria is mandatory. Since the emergence of HIV/AIDS, it has been the greatest health hazards ever faced by mankind. HIV/AIDS epidemic has already killed more than 20 million people globally. At present more than 40 million people living with HIV/AIDS all over the world. In South East Asian countries more than 6.7 million people living with HIV/AIDS. About 3 million peoples are dying of HIV/AIDS every year. 2 To determine the prevalence of HBV and HCV, comprehensive study has yet to be done. However, different studies have shown that there is significant number of HBV and HCV carriers in Bangladesh. Due to emergence of HBV mutants, for blood safety, their implications have become a major concern for research. One study of 576 apparently healthy male adults revealed that 7.8% were HBV carriers and about 60% of post transfusion hepatitis due to HBV 3 . Another study conducted among 163 professional donors and 83 voluntary donors revealed that 1.2% professional donors were sero-positive for HCV and 29% of the voluntary donors were HBsAg positive. 4 This study may be useful in formulating transfusion therapy and also in developing prevention policy for safe blood.
Materials and Methods
A cross sectional descriptive study was carried out in the Blood Transfusion Department of Chittagong Medical College Hospital (CMCH) during the period of January 2009 to December 2009 to determine the seropositivity of TTIs markers in blood donors. Data of routine screening reports of blood donors were collected from blood bank coming to blood transfusion department of this institution. A total of 33,553 blood donors attending the blood bank This table shows that the percentage of male blood donors were more than 4 times higher than female blood donors. Age group of 26-45 years blood donors were higher incidence of blood donations. Results of this study shown that 1.12% of total blood donors have TTIs, prevalence of HBV infection was higher than other TTIs markers. (4.57%) were female. HCV was reactive in 23 (0.068%) donors, out of which 18 (78.24%) was male and 5 (21.76%) were female. Syphilis was reactive in 32 (0.095%) donors, out of which 29 (90.62%) was male and 3 (9.38%) were female. Malaria was reactive in 31(0.09%) donors all of which were male. The prevalence of HIV, HBV, and HCV and Syphilis positivity in Indian blood donors is HIV-0.084% to 3.87%, HBV -0.66% to 12%, HCV -0.5% to 1.5% and Syphilis -0.85% to 3% respectively. 5 The present study revealed seroprevalence of HIV 0.02% in the donors lower as reported by other studies. 8, 6 The seroprevalence of HBV was 0.84% similar to that reported by the other studies 0.99%8 and 0.66 %, 7 whereas variable results of 2.45 %, 8 5.86 %, 25% 9 have also been reported. The seroprevalence of HCV was 0.068% which is much lower as reported by other studies 0.19%8, 0.88%, 10 1.09% 11 and 6.21%. 12 The seroprevalence of Syphilis was 0.095% in the present study which is lower than other studies. 13 The decrease in seroprevalence of TTIs markers may have been mainly associated with improved donor selection practices according to definite criteria and exclusion of repeat donors screened reactive on previous donation. In a study it has been estimated that the risk was 1in 89,000 donations collected in the window period of organism. History of blood donors during interview, discussion and awareness, motivation on blood safety among blood donors has considerable impact on reduction of TTIs markers and thereby reducing morbidity and mortality.
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Conclusion:
The study does not reflect the actual sero-prevalence of TTIs markers among the blood donors of the country. To improve the effectiveness of screening up to desirable level there should be detection of post-transfusion TTIs markers. The evaluation of testing techniques is to be done from time to time and their regular monitoring by periodic External Quality Assurance System (EQAS). Recruitment of low risk voluntary blood donors should be strictly maintained. Every reporting should be done by improved system available at the centre concerned. Overall, the findings of the study are an encouraging one and support the decrease in trends of sero-prevalence of TTIs markers in this region of the country. It is important to follow the WHO guidelines to screen every donor for HBV, HCV, HIV, Syphilis and Malaria to decrease the transmission of TTIs. Record keeping should be promoted to follow up the screened patients. However, extensive and multi center studies are needed to find out the prevalence of two or three TTIs markers in the same individuals.
